Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

Journal of Hematology & Oncology

  • h-index: 196
  • Total citations: 157,213
  • Total papers: 1,782
  • Impact factor: 28.40531561461794

Homepage: https://link.springer.com/journal/13045

Journal of Hematology & Oncology

Journal
Visit website →
H-Index = 196
Citations = 157.21K+

Papers

Evidence

Recent papers in Journal of Hematology & Oncology

  1. Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumorsJournal of Hematology & Oncology · Tue,
  2. Cytokine fusion proteins for solid tumor therapy: mechanistic insights and clinical advancesJournal of Hematology & Oncology · Sat,
  3. Glutathione reductase deficiency potentiates the immunogenicity of ferroptosis and cuproptosis via amplified reactive oxygen species accumulation and cGAS-STING pathway activationJournal of Hematology & Oncology · Tue,
  4. High-definition spatial transcriptomics visualizes the cellular and molecular architecture underlying perineural invasion in localized prostate cancerJournal of Hematology & Oncology · Tue,
  5. Mucosal immunity: mechanism and application in cancer immunotherapyJournal of Hematology & Oncology · Tue,
  6. Current and future therapies for triple-negative breast cancerJournal of Hematology & Oncology · Wed,
  7. The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026Journal of Hematology & Oncology · Sat,
  8. A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasmJournal of Hematology & Oncology · Fri,
  9. A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirectionJournal of Hematology & Oncology · Thu,
  10. Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level dataJournal of Hematology & Oncology · Mon,

About Journal of Hematology & Oncology

Journal of Hematology & Oncology carries 1,782 indexed papers, 157,213 citations, h-index 196 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Journal of Hematology & Oncology sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at https://link.springer.com/journal/13045.

Use the feed below to follow new Journal of Hematology & Oncology publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 111 words.